Citrate Suppresses Tumor Growth in Multiple Models through Inhibition of Glycolysis, the Tricarboxylic Acid Cycle and the IGF-1R Pathway
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Citrate Suppresses Tumor Growth in Multiple Models through Inhibition of Glycolysis, the Tricarboxylic Acid Cycle and the IGF-1R Pathway
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-06-27
DOI
10.1038/s41598-017-04626-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas
- (2016) Audrey Bouillez et al. CANCER RESEARCH
- The reduced concentration of citrate in cancer cells: An indicator of cancer aggressiveness and a possible therapeutic target
- (2016) Icard Philippe et al. DRUG RESISTANCE UPDATES
- Mucin 1-mediated chemo-resistance in lung cancer cells
- (2016) S Y Ham et al. Oncogenesis
- Clinical significance of IGF1R gene expression in patients with Stage II/III gastric cancer who receive curative surgery and adjuvant chemotherapy with S-1
- (2015) Koji Numata et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Targeting Lactate Dehydrogenase-A Inhibits Tumorigenesis and Tumor Progression in Mouse Models of Lung Cancer and Impacts Tumor-Initiating Cells
- (2014) Han Xie et al. Cell Metabolism
- Citrate Synthase Expression Affects Tumor Phenotype and Drug Resistance in Human Ovarian Carcinoma
- (2014) Lilan Chen et al. PLoS One
- Expression of insulin-like growth factor receptor type 1 correlate with lymphatic metastases in human gastric cancer
- (2014) Mariusz Gryko et al. POLISH JOURNAL OF PATHOLOGY
- MUC1: a multifaceted oncoprotein with a key role in cancer progression
- (2014) Sritama Nath et al. TRENDS IN MOLECULAR MEDICINE
- Knockdown of Malic Enzyme 2 Suppresses Lung Tumor Growth, Induces Differentiation and Impacts PI3K/AKT Signaling
- (2014) Jian-Guo Ren et al. Scientific Reports
- A critical role for citrate metabolism in LPS signalling
- (2013) Luke A. J. O'Neill BIOCHEMICAL JOURNAL
- Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
- (2013) Madhusudhanan Sukumar et al. JOURNAL OF CLINICAL INVESTIGATION
- Spermine and Citrate as Metabolic Biomarkers for Assessing Prostate Cancer Aggressiveness
- (2013) Guro F. Giskeødegård et al. PLoS One
- PTEN-regulated AKT/FoxO3a/Bim signaling contributes to reactive oxygen species-mediated apoptosis in selenite-treated colorectal cancer cells
- (2013) H Luo et al. Cell Death & Disease
- ATP citrate lyase knockdown impacts cancer stem cells in vitro
- (2013) J-i Hanai et al. Cell Death & Disease
- Inhibition of Mcl-1 expression by citrate enhances the effect of Bcl-xL inhibitors on human ovarian carcinoma cells
- (2013) Hubert Lincet et al. Journal of Ovarian Research
- Citrate kills tumor cells through activation of apical caspases
- (2012) Björn Kruspig et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Small Interfering RNA Targeted to IGF-IR Delays Tumor Growth and Induces Proinflammatory Cytokines in a Mouse Breast Cancer Model
- (2012) Tiphanie Durfort et al. PLoS One
- A model for cancer-suppressive inflammation
- (2012) Ole Audun Werner Haabeth et al. OncoImmunology
- The mitochondrial citrate carrier: a new player in inflammation
- (2011) Vittoria Infantino et al. BIOCHEMICAL JOURNAL
- Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen-activated protein Kinase (MAPK) and Phosphatidylinositol-3-kinase (PI3K)/AKT pathways
- (2011) Jun-ichi Hanai et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Clinical report: A patient with primary peritoneal mesothelioma that has improved after taking citric acid orally
- (2011) A.H. Bucay Clinics and Research in Hepatology and Gastroenterology
- High IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines and Tumorgrafts Correlates with Sensitivity to Anti-IGF-IR Therapy
- (2010) B. C. Litzenburger et al. CLINICAL CANCER RESEARCH
- Insulin-Like Growth Factor-I Regulation of Immune Function: A Potential Therapeutic Target in Autoimmune Diseases?
- (2010) T. J. Smith PHARMACOLOGICAL REVIEWS
- Induction of Erythroid Differentiation in Human Erythroleukemia Cells by Depletion of Malic Enzyme 2
- (2010) Jian-Guo Ren et al. PLoS One
- Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non–Small-Cell Lung Cancer
- (2009) Daniel D. Karp et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypothesis proved…citric acid (citrate) does improve cancer: A case of a patient suffering from medullary thyroid cancer
- (2009) Alberto Halabe Bucay MEDICAL HYPOTHESES
- High Expression Levels of Total IGF-1R and Sensitivity of NSCLC Cells In Vitro to an Anti-IGF-1R Antibody (R1507)
- (2009) Yixuan Gong et al. PLoS One
- Tumor Suppression by PTEN Requires the Activation of the PKR-eIF2 Phosphorylation Pathway
- (2009) Z. Mounir et al. Science Signaling
- Insulin, insulin-like growth factors and neoplasia
- (2008) Michael Pollak BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Targeting insulin and insulin-like growth factor signalling in oncology
- (2008) Michael Pollak CURRENT OPINION IN PHARMACOLOGY
- Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis
- (2008) R. Brooks Robey et al. SEMINARS IN CANCER BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search